1
EXHIBIT (11)
STATEMENT REGARDING COMPUTATION OF EARNINGS PER SHARE
DURAMED PHARMACEUTICALS, INC.
Three months ended March 31,
1995 1994
------------- ------------
Primary:
Weighted average common shares
outstanding 7,984,078 7,723,452
Net effect of preferred shares
converted to common shares -
based on the treasury stock
method using the average
market price 746,590 676,109
Net effect of dilutive stock
options and warrants - based
on the treasury stock method
using the average market price 1,980,378 1,507,956
----------- -----------
Totals 10,711,046 9,907,517
=========== ===========
Net income $ 1,008,347 $ 1,241,037
=========== ===========
Per share amount $ .09 $ .13
=========== ===========
Fully diluted:
Weighted average common
shares outstanding 7,984,078 7,723,452
Net effect of preferred shares
converted to common shares -
based on the treasury stock
method using the quarter-end
market price 746,590 680,568
Net effect of dilutive stock
options and warrants - based
on the treasury stock method
using the quarter-end market 1,983,282 1,538,332
----------- -----------
Totals 10,713,950 9,942,352
=========== ===========
Net income $ 1,008,347 $ 1,241,037
=========== ===========
Per share amount $ .09 $ .12
=========== ===========
- 18 -